Plasma Fractionation Market Size, Share & Forecast to 2030

Plasma fractionation plays a vital role in global healthcare by delivering high-purity therapeutic proteins critical for treating a growing range of complex conditions. Senior executives tasked with navigating supply, regulatory, and innovation challenges will find this market overview especially relevant for strategic planning and investment decisions.

Market Snapshot: Plasma Fractionation Market Growth Outlook

The Plasma Fractionation Market grew from USD 36.77 billion in 2024 to USD 40.22 billion in 2025. It is expected to continue growing at a CAGR of 9.65%, reaching USD 63.94 billion by 2030. Key growth drivers include the increasing demand for plasma-derived products in hematology, immunology, and neurology, coupled with ongoing innovation and regulatory changes that are shaping industry dynamics. Primary and secondary research confirm that sustained investment in advanced processing and stringent quality management directly influence market performance.

Scope & Segmentation

This report provides comprehensive coverage of the plasma fractionation market, offering in-depth analysis across multiple dimensions:

Product Type: Albumin, Coagulation Factor Concentrates, Immunoglobulins (including both intravenous and subcutaneous formulations), Protease Inhibitors.
Method of Fractionation: Centrifugation, Cryoprecipitation, Ethanol Precipitation, Ion-Exchange Chromatography, Ultrafiltration.
Application: Hematology, Neurology, Oncology, Rheumatology.
End-User: Academic Institutions, Clinical Research Laboratories, Hospitals & Clinics.
Geography: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering United Kingdom, Germany, France, among others), and Asia-Pacific (particularly China, India, Japan, Australia, and other emerging and mature markets).
Technology Adoption: Advanced chromatography, continuous processing systems, digital monitoring tools, process control analytics, and adoption of sustainable purification methodologies.

This extensive segmentation allows decision-makers to identify strategic opportunities based on geography, therapeutic focus, and operational methodologies—supporting resource prioritization and risk mitigation.

Key Takeaways for Senior Decision-Makers

Competitive advantage is increasingly gated by access to advanced fractionation technology and the ability to rapidly adapt to regulatory shifts.
Diversification of sourcing and supplier relationships is critical for stability amid evolving trade regimes and tariff changes, reducing exposure to single-region risks.
Immunoglobulins drive recurring revenue streams, while specialized coagulation factors and protease inhibitors enable targeted access to niche indications.
Geographic expansion strategies must address regional regulatory landscapes and local patient needs to ensure compliance and market relevance.
Investments in digital process analytics and continuous production are delivering measurable gains in yield and quality assurance.
Sustainability initiatives and talent development programs are gaining prominence, shaping long-term operational resilience and supporting competitive performance.

Tariff Impact on Supply Chains and Global Trade

Recent tariff measures enacted by the United States have raised plasma fractionation input costs, affecting procurement of equipment and specialized raw materials. These duties have led organizations to reassess supply partnerships, adopt near-sourcing strategies, and secure multiyear contracts for key reagents. In response, some companies are diversifying fractionation methods to decrease reliance on tariff-sensitive materials. Reciprocal actions by international trade partners have also prompted more distributed sourcing and strategic alliances, safeguarding continuity and offsetting increased supply chain expenses.

Methodology & Data Sources

This report utilizes a multi-stage research methodology, combining structured interviews with senior industry figures, process engineers, and regulatory specialists, with rigorous secondary research across journals, regulatory filings, and proprietary industry databases. Advanced data validation techniques ensure analytical accuracy and actionable insights.

Why This Report Matters

Enables C-suite executives to benchmark corporate strategies and pipeline investments against leading industry trends and regional developments.
Equips procurement and operations leaders with evidence-based insights to optimize supplier networks and mitigate emerging trade and regulatory risks.
Facilitates informed, forward-looking planning that aligns technology upgrades and segment expansion with evolving quality standards and market demand.

Conclusion

The plasma fractionation market is defined by rapid technological progress, evolving regulatory requirements, and increased demand for targeted therapies. Senior leadership that embraces innovation, builds agile supply networks, and prioritizes compliance will be well-positioned for sustained growth and competitiveness.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

5.1. Expansion of recombinant therapies driving shifts in traditional plasma fractionation volumes
5.2. Integration of continuous flow processing to improve efficiency and reduce production costs in plasma fractionation
5.3. Rising demand for immunoglobulin therapies prompting increased investments in global plasma collection infrastructure
5.4. Regulatory harmonization challenges affecting cross-border plasma fractionation and final product distribution
5.5. Adoption of nanofiltration and viral inactivation technologies enhancing safety profiles of plasma-derived products
5.6. Strategic partnerships between biopharma and contract manufacturers to expand plasma fractionation capacity worldwide
5.7. Emerging markets driving growth in plasma-derived albumin demand amid increasing surgical and critical care procedures
5.8. Impact of donor recruitment digital platforms on plasma supply stability and collection center utilization rates

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Plasma Fractionation Market, by Product Type

8.1. Introduction
8.2. Albumin
8.3. Coagulation Factor Concentrates
8.4. Immunoglobulins
8.4.1. Intravenous Immunoglobulin
8.4.2. Subcutaneous Immunoglobulin
8.5. Protease Inhibitors

9. Plasma Fractionation Market, by Method of Fractionation

9.1. Introduction
9.2. Centrifugation
9.3. Cryoprecipitation
9.4. Ethanol Precipitation
9.5. Ion-Exchange Chromatography
9.6. Ultrafiltration

10. Plasma Fractionation Market, by Application

10.1. Introduction
10.2. Hematology
10.3. Neurology
10.4. Oncology
10.5. Rheumatology

11. Plasma Fractionation Market, by End-User

11.1. Introduction
11.2. Academic Institutions
11.3. Clinical Research Laboratories
11.4. Hospitals & Clinics

12. Americas Plasma Fractionation Market

12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina

13. Europe, Middle East & Africa Plasma Fractionation Market

13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland

14. Asia-Pacific Plasma Fractionation Market

14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan

15. Competitive Landscape

15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. 3M Company
15.3.2. ADMA Biologics, Inc.
15.3.3. Bharat Serums and Vaccines Limited
15.3.4. Bio Products Laboratory Ltd.
15.3.5. Biotest AG by Grifols, S.A.
15.3.6. China Biologic Products, Inc.
15.3.7. CSL Limited
15.3.8. Emergent BioSolutions Inc.
15.3.9. GC Biopharma corp.
15.3.10. HEINKEL Process Technology GmbH
15.3.11. Hemarus Therapeutics Ltd
15.3.12. Intas Pharmaceuticals Ltd.
15.3.13. Kamada Ltd.
15.3.14. Kedrion S.p.A.
15.3.15. LFB SA
15.3.16. Merck KGaA
15.3.17. Octapharma AG
15.3.18. PlasmaGen BioSciences Pvt. Ltd.
15.3.19. Prothya Biosolutions B.V.
15.3.20. Shanghai Raas Blood Products Co. Ltd.
15.3.21. SK Plasma Co.,Ltd.
15.3.22. STERIS plc
15.3.23. Takeda Pharmaceutical Company Ltd.

16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix

List of Figures

FIGURE 1. PLASMA FRACTIONATION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PLASMA FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PLASMA FRACTIONATION MARKET: RESEARCHAI
FIGURE 24. PLASMA FRACTIONATION MARKET: RESEARCHSTATISTICS
FIGURE 25. PLASMA FRACTIONATION MARKET: RESEARCHCONTACTS
FIGURE 26. PLASMA FRACTIONATION MARKET: RESEARCHARTICLES

List of Tables

TABLE 1. PLASMA FRACTIONATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRYOPRECIPITATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRYOPRECIPITATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ETHANOL PRECIPITATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ETHANOL PRECIPITATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ION-EXCHANGE CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ION-EXCHANGE CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. CANADA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. CANADA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 82. CANADA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 83. CANADA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 84. CANADA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 85. CANADA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. CANADA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. CANADA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 88. CANADA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 89. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 92. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 93. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 94. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 95. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 98. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 136. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 141. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 144. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 145. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 146. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 147. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 150. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 151. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 154. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 155. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 156. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 157. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 160. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 165. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 166. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 167. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 170. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 171. ITALY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. ITALY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. ITALY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 174. ITALY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 175. ITALY PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 176. ITALY PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 177. ITALY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. ITALY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. ITALY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 180. ITALY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 181. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 184. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 185. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 186. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 187. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 190. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 206. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 210. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 216. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 220. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 221. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 224. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 225. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 226. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 227. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 230. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 235. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 236. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 237. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 240. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 241. QATAR PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. QATAR PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. QATAR PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 244. QATAR PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 245. QATAR PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 246. QATAR PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 247. QATAR PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. QATAR PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. QATAR PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 250. QATAR PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 251. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 254. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 255. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 256. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 257. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 260. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 265. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 266. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 267. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 270. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 275. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 276. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 277. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 280. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 281. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 284. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 285. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 286. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 287. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 290. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 291. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 294. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 295. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 296. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 297. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 300. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 305. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 306. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 307. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 310. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 311. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 312. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 313. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 314. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 315. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 316. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 317. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 320. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 321. POLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. POLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. POLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 324. POLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 325. POLAND PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2024 (USD MILLION)
TABLE 326. POLAND PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025-2030 (USD MILLION)
TABLE 327. POLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. POLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. POLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 330. POLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 331. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2024 (USD MILLION)
TABLE 334. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2025-2030 (USD MILLION)
TABLE 335. SWITZERLAND PL

Samples

LOADING...

Companies Mentioned

3M Company
ADMA Biologics, Inc.
Bharat Serums and Vaccines Limited
Bio Products Laboratory Ltd.
Biotest AG by Grifols, S.A.
China Biologic Products, Inc.
CSL Limited
Emergent BioSolutions Inc.
GC Biopharma corp.
HEINKEL Process Technology GmbH
Hemarus Therapeutics Ltd
Intas Pharmaceuticals Ltd.
Kamada Ltd.
Kedrion S.p.A.
LFB SA
Merck KGaA
Octapharma AG
PlasmaGen BioSciences Pvt. Ltd.
Prothya Biosolutions B.V.
Shanghai Raas Blood Products Co. Ltd.
SK Plasma Co.,Ltd.
STERIS plc
Takeda Pharmaceutical Company Ltd.

Table Information

Report Attribute	Details
No. of Pages	195
Published	August 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 40.22 Billion
Forecasted Market Value ( USD ) by 2030	$ 63.94 Billion
Compound Annual Growth Rate	9.6%
Regions Covered	Global
No. of Companies Mentioned	23

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3156EUR$3,545USD£2,726GBP €3506EUR$3,939USD£3,029GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3404EUR$3,824USD£2,941GBP €3782EUR$4,249USD£3,268GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4614EUR$5,183USD£3,986GBP €5126EUR$5,759USD£4,429GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5583EUR$6,272USD£4,823GBP €6203EUR$6,969USD£5,359GBP

Plasma Fractionation Market by Product Type (Albumin, Coagulation Factor Concentrates, Immunoglobulins), Method of Fractionation (Centrifugation, Cryoprecipitation, Ethanol Precipitation), Application, End-User - Global Forecast 2025-2030

Market Snapshot: Plasma Fractionation Market Growth Outlook